| Tag | Content |
|---|
EnhancerAtlas ID | HS101-25251 |
Organism | Homo sapiens |
Tissue/cell | HT29 |
Coordinate | chr2:165788920-165791280 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXA1 | MA0148.4 | chr2:165790443-165790459 | AGTTAAGTAAATAATC | + | 6.17 | | RFX1 | MA0509.2 | chr2:165790054-165790070 | TGTTTCCATAGTAACA | - | 6.06 | | RFX1 | MA0509.2 | chr2:165790054-165790070 | TGTTTCCATAGTAACA | + | 6.08 | | RFX2 | MA0600.2 | chr2:165790054-165790070 | TGTTTCCATAGTAACA | + | 6.31 | | RFX2 | MA0600.2 | chr2:165790054-165790070 | TGTTTCCATAGTAACA | - | 6.36 | | RFX5 | MA0510.2 | chr2:165790054-165790070 | TGTTTCCATAGTAACA | + | 6.33 | | RFX5 | MA0510.2 | chr2:165790054-165790070 | TGTTTCCATAGTAACA | - | 6.3 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_29020 | chr2:165789707-165790820 | Fetal_Intestine_Large |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I164933 | chr2 | 165790086 | 165795249 |
|
Enhancer Sequence | GTATATACCA AAGGAATATA GATGGTTTTA TCATAAAAAC ATGTAAATGG TCACAATAGC 60
AAAGACATGG AATCAACCTA AATGTCCATT AATGGCAGAC TGGATAAAGA AAATGTGGTA 120
CATGTACACC ATGGAATACT ATGCAGCCAT AAAAAGATCA TGTCCTCTGC AGGAACGTGG 180
ATTGAGCTGG AGAGGGCATT ATCCTTAGCA AACTAATGCA GGAAAAGAAA AGTAAAGAAC 240
ACATATTCTC ATTTATAAGC GGGAGCTAAA AGATCACAAC ACATGGACAC AGAGAGGGGA 300
ACAACACACA CTGGGACCTA TCAGAGGGTG GAAGTTGGGA GAAAGAAGAA GATCAGGAAA 360
GATAACTAAT GGGTACTAGG CTTCATACTT AGGTGACGAA ATAATCGGTA CAACAAACTC 420
CCATGATACA AGTTTACCTA TATAACAAAC CTGCACATGT ACCCCTGAAC TTAAAAATTC 480
AGTGGCTAAT ATTCGTCAGA ATGAATCATT TCTTTCCTTA AATATGTAGC CTTCCTCTGT 540
CTTTACCCAT TTTTAAAAAT CCTTTTCTTA ACCCCCTCTA GTTCTTCTTT ATGTGTAGCA 600
TAAAACTGCA GAATTCAGGG TTTGAATGTA TAAGGGTTAA GGAAACTAAT GTGCATTGAG 660
ATTAAAATTT AAAGTATGGA CTCACTTTTT GGAATTTTGT TTAGAATACC ACACGATTAA 720
AATGCTGTAA GAAAGATGTC ATATGAGGGG AAAATAGTTG TAAATTTGGA CTGCATGTTA 780
TAATTTCCAT TCTGAATGTA AAGAATTGAA TATTAATAAG GCATTAAATG AAGGGTTTTT 840
TTTTAACAGT GATAATGCCT CTGATTCTAG TTAGAAAAAA ATTGGGAGAA CTGTTATTGT 900
ATTTTTATAC TAGCACACTT TCTGAAAAGC AATTAAATTT CCTTGCCACC TCAGTTTTTA 960
GAAAGCAAAA GGTTAGAAAA TACCATAAAT CTGAACATAA TTTCCAAAAA ACCTGAAAGT 1020
CATTGGACTG TGAGATATCT GAAATCGTAT CAAAAAGTAG AATTTATGGC CCTATAAGTT 1080
ATGGAAAAGG AAATTGAATT GTATTTTATT TTTAAAACAT AACCACTAAA ATGATGTTTC 1140
CATAGTAACA AGGTCAATAC CAGTAGCCAT TATAGACCTT CCCCTTTTCT GATAGTGGGT 1200
TTAAAGATCT TTTTCAAACA CCACTTTAAA AGACCTATGA AAAAACCACA GGTTTTCTGA 1260
TCATTCATCT GAACCGAAAA TGAAGAAAAC CACACATGGA GTATTGAATT TCTCATGTTT 1320
TATGGATTAC AAGCATTCAT CGCTGTCATA TTTTCAGAAA GAAGCCTGCC TGACTAGCTA 1380
CCATGCCAAC TCCTGAACTT GGGATTTGAT TAGCCTGATT GTAAATCAGG ATGAACAGAA 1440
GTTGTTTGCA GTAGTATTCA AACAGACATA AAAGGTGGCA CAGTATTAAA AAACATACTT 1500
CTTTAACATC TAAATATTGA AAGAGTTAAG TAAATAATCC TTGCTATTAC ATTTCAAAGG 1560
CTCAGATAAA ATATTGTATC ACTACTAGAG GAAGGTCAGA CAGATGTAGG CCACATTTTG 1620
TTGACAACAG AACTAAATAG CTATTTGGCC ATAAAAATCA TTTCATTGAG CCCCACCAGG 1680
AAGTGGACTG CCCTTCCTTT TTTCTCTATA TCAAGGCACA CTGCTTATAT GATAGTCATT 1740
TGTATAGCTT TGTCTTCTTC ACTAAACTGC GAGCCCCTTA AAAGCAGAGA TATTTTATTT 1800
CTCTATGTAT TCATGACAGT ATTTCACATG ACACTTTGTA CATAAAAAAT ACTGAAAGAA 1860
ACAAGCGGAG AATGCATCAT GAAAAATGAT CACAAAACAG TAACTAAAAT AACACAAAAT 1920
CTCTGGTTTA ATTTTAGAAA CAATGTGTCA GTTAAAAATA TGTACTCATT ATTTTAATCT 1980
CTTTAAACCA AGAGGCTTTA GAATCTTTGT TCATAGAATC TCCAATGGCG AAATAATGAA 2040
TCCAATTGCC TGGCCCCTAG ATCAATTCCT TCAGAATCTC TACAGGTGGG GCTCTGGCAT 2100
CAGTATTTTC TAAAGTTACT CAGATGATTC TCATGTGAAA CAAGTGTTGA GAATCATTGC 2160
TTTACACTGT TCTCCCGTGG TGCAACTGAG GATTAATTTA CTTCCTACTT TAGCTATGTT 2220
TCCCCCTCAA TATTGCCTCA TAATACTATA TTTAGCAAAC CTATAAGAAC TTTTATTACA 2280
ACCCAGTGAT TTTTTTCCCT GTAAACACTT TTTATAATAA AAATTATCAA TTAAAACAGT 2340
TTGGTCTTAC ACAATTAAAA 2360
|
